J&J | JNJ - Interest Income

Stock Price
225.31
Daily Change
-2.19 -0.96%
Monthly
-7.08%
Yearly
45.03%
Q2 Forecast
222.63

J&J reported $2.14 in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Abbott USD 78M 1000K Dec/2025
AstraZeneca USD 85M 17M Sep/2025
Baxter International USD 10M 4M Sep/2025
Bayer EUR 130M 38M Sep/2025
Becton, Dickinson and Co. USD 4M 1000K Dec/2025
Biogen USD 31.6M 700K Sep/2025
Boston Scientific USD 4M 3M Dec/2022
Dexcom USD 32.7M 4.7M Sep/2025
Edwards Lifesciences USD 56.3M 17.7M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Globus Medical USD 815K 3.08M Dec/2024
Insulet USD 8.6M 1.5M Sep/2025
Integra LifeSciences USD 4.98M 272K Sep/2025
Intuitive Surgical USD 91.3M 4.2M Dec/2025
J&J USD 2.14 237M Mar/2026
Medtronic USD 114M 23M Jan/2025
Merck USD 96M 27M Sep/2025
Merit Medical Systems USD 3.62M 146K Sep/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 33M 81M Dec/2025
Stryker USD 38M 9M Mar/2025
Tandem Diabetes Care USD 2.51M 1.68M Sep/2025
Vertex Pharmaceuticals USD 125.7M 3.3M Sep/2025
Zoetis USD 26M 7M Sep/2025